This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: The Medical College of Wisconsin, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: **Innovative Contributions of Abdul Hye Khan in Kidney Disease Treatment**
Introduction
Abdul Hye Khan, an innovative inventor based in Milwaukee, WI, has made significant strides in the realm of medical advancements, particularly focusing on treatments for kidney disease. His work exemplifies the intersection of research and practical application, showcasing the vital role inventors play in healthcare innovation.
Latest Patents
Abdul Hye Khan holds a remarkable patent for "Substituted epoxyeicosatrienoic acid (EET) analogs for treatment of kidney disease." This patent describes EET analogs that are conjugated to folate receptor ligands, such as folic acid or its analogs, which are selectively recognized and bound by folate receptors and other folate-binding proteins. Notably, these conjugated EET analogs are utilized for the targeted delivery of therapeutic agents to folate-receptor bearing cell populations, thus offering promising advances in kidney-targeted therapeutics.
Career Highlights
Khan is associated with the Medical College of Wisconsin, Inc., where he is part of a dedicated team driving forward medical research and innovation. His contributions to the field have not only enhanced understanding but also provided new avenues for effective treatments in nephrology.
Collaborations
Throughout his career, Abdul Hye Khan has collaborated with notable colleagues, including John David Imig and John Russell Falck. These partnerships have allowed for the exchange of ideas and collective efforts towards significant medical breakthroughs that could ultimately improve patient outcomes.
Conclusion
Abdul Hye Khan's inventive work in the development of targeted therapies for kidney disease serves as a testament to the critical role of inventors in advancing medical science. His patented technologies represent not only personal achievement but also a substantial contribution to healthcare, reflecting the ongoing need for innovation in treating complex diseases.